Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Cadoo K, Simpkins F, Mathews C, Liu YL, et al. Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis. Gynecol Oncol 2022 Jul 5. pii: S0090-8258(22)00421.
PMID: 35803835


Privacy Policy